Loading…
Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis
Objective In the spondyloarthritides (SpA), increased numbers of CD4+ T cells express killer cell immunoglobulin‐like receptor 3DL2 (KIR‐3DL2). The aim of this study was to determine the factors that induce KIR‐3DL2 expression, and to characterize the relationship between HLA–B27 and the phenotype a...
Saved in:
Published in: | Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2016-04, Vol.68 (4), p.901-914 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93 |
---|---|
cites | cdi_FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93 |
container_end_page | 914 |
container_issue | 4 |
container_start_page | 901 |
container_title | Arthritis & rheumatology (Hoboken, N.J.) |
container_volume | 68 |
creator | Ridley, Anna Hatano, Hiroko Wong‐Baeza, Isabel Shaw, Jacqueline Matthews, Katherine K. Al‐Mossawi, Hussein Ladell, Kristin Price, David A. Bowness, Paul Kollnberger, Simon |
description | Objective
In the spondyloarthritides (SpA), increased numbers of CD4+ T cells express killer cell immunoglobulin‐like receptor 3DL2 (KIR‐3DL2). The aim of this study was to determine the factors that induce KIR‐3DL2 expression, and to characterize the relationship between HLA–B27 and the phenotype and function of KIR‐3DL2–expressing CD4+ T cells in SpA.
Methods
In total, 34 B27+ patients with SpA, 28 age‐ and sex‐matched healthy controls (20 B27− and 8 B27+), and 9 patients with rheumatoid arthritis were studied. KIR-3DL2 expression and other phenotypic characteristics of peripheral blood and synovial fluid CD4+ T cells were studied by flow cytometry, quantitative polymerase chain reaction, and Western blotting. T cell receptor clonality was determined by template‐switch anchored reverse transcription–polymerase chain reaction and sequencing analysis. Cytokines were measured by enzyme‐linked immunosorbent assay.
Results
Cellular activation induced KIR‐3DL2 expression on both naive and effector CD4+ T cells. KIR‐3DL2 binding to B27+ cells promoted expression of KIR‐3DL2, the Th17‐specific transcription factor retinoic acid receptor–related orphan nuclear receptor γt, and the antiapoptotic factor B cell lymphoma 2. KIR‐3DL2+CD4+ T cells in patients with ankylosing spondylitis were oligoclonal and enriched for markers of T cell activation and for the gut homing receptor CCR9. In the presence of B27+ antigen‐presenting cells, KIR‐3DL2+CD4+ T cells produced less interleukin‐2 (IL‐2) but more IL‐17. This effect was blocked by HC10, an antibody that inhibits the binding of KIR‐3DL2 to B27 heavy chains.
Conclusion
KIR‐3DL2 binding to HLA–B27 licenses Th17 cell differentiation in SpA. These findings raise the therapeutic potential of targeting HLA–B27–KIR‐3DL2 interactions for the treatment of B27+ patients with SpA. |
doi_str_mv | 10.1002/art.39515 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4855641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1777487542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93</originalsourceid><addsrcrecordid>eNqNktFqFDEYhQdRbFl74QtIwBu92HaSTJKZG2G7Vbu4oNT1OmQy_-ymZpJtMlPZuz5CoVe-Xp_EbLctKgjmJoH_4-Q_h5NlL3F-iPOcHKnQH9KKYfYk2yeU8DEjOXv68MYV3ssOYjzP06lEznP2PNsjvCwwZXQ_-znRvblUvfHu9up65ppBQ4M-GWshoClYi2ZdNzi_tL4erNlC1nwHdAYa1r0PiJ7MCTo2rjFuiXqPTueT26ubYyLQ3GhwESL6ovqVX4IzGi12miembSGA683dz8g49HXtXbOxPtlZBdOb-CJ71iob4eD-HmXfPrxfTE_H888fZ9PJfKwLwdm4ZboGwjgvAbiodCWKoimp4LimWFWV4lTjZFsVbZMDNIVmTZ0iAkp0yaGio-zdTnc91B00aec-KCvXwXQqbKRXRv45cWYll_5SFiVjPMU4yt7cCwR_MUDsZWeiTjaVAz9EiUXJCC0xzf8DFaIoBStIQl__hZ77IbiUxJbiVGDGtoJvd5QOPsYA7ePeOJfbesiUp7yrR2Jf_W70kXwoQwKOdsAPY2HzbyU5OVvsJH8BxV7IKQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776371550</pqid></control><display><type>article</type><title>Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Ridley, Anna ; Hatano, Hiroko ; Wong‐Baeza, Isabel ; Shaw, Jacqueline ; Matthews, Katherine K. ; Al‐Mossawi, Hussein ; Ladell, Kristin ; Price, David A. ; Bowness, Paul ; Kollnberger, Simon</creator><creatorcontrib>Ridley, Anna ; Hatano, Hiroko ; Wong‐Baeza, Isabel ; Shaw, Jacqueline ; Matthews, Katherine K. ; Al‐Mossawi, Hussein ; Ladell, Kristin ; Price, David A. ; Bowness, Paul ; Kollnberger, Simon</creatorcontrib><description>Objective
In the spondyloarthritides (SpA), increased numbers of CD4+ T cells express killer cell immunoglobulin‐like receptor 3DL2 (KIR‐3DL2). The aim of this study was to determine the factors that induce KIR‐3DL2 expression, and to characterize the relationship between HLA–B27 and the phenotype and function of KIR‐3DL2–expressing CD4+ T cells in SpA.
Methods
In total, 34 B27+ patients with SpA, 28 age‐ and sex‐matched healthy controls (20 B27− and 8 B27+), and 9 patients with rheumatoid arthritis were studied. KIR-3DL2 expression and other phenotypic characteristics of peripheral blood and synovial fluid CD4+ T cells were studied by flow cytometry, quantitative polymerase chain reaction, and Western blotting. T cell receptor clonality was determined by template‐switch anchored reverse transcription–polymerase chain reaction and sequencing analysis. Cytokines were measured by enzyme‐linked immunosorbent assay.
Results
Cellular activation induced KIR‐3DL2 expression on both naive and effector CD4+ T cells. KIR‐3DL2 binding to B27+ cells promoted expression of KIR‐3DL2, the Th17‐specific transcription factor retinoic acid receptor–related orphan nuclear receptor γt, and the antiapoptotic factor B cell lymphoma 2. KIR‐3DL2+CD4+ T cells in patients with ankylosing spondylitis were oligoclonal and enriched for markers of T cell activation and for the gut homing receptor CCR9. In the presence of B27+ antigen‐presenting cells, KIR‐3DL2+CD4+ T cells produced less interleukin‐2 (IL‐2) but more IL‐17. This effect was blocked by HC10, an antibody that inhibits the binding of KIR‐3DL2 to B27 heavy chains.
Conclusion
KIR‐3DL2 binding to HLA–B27 licenses Th17 cell differentiation in SpA. These findings raise the therapeutic potential of targeting HLA–B27–KIR‐3DL2 interactions for the treatment of B27+ patients with SpA.</description><identifier>ISSN: 2326-5191</identifier><identifier>EISSN: 2326-5205</identifier><identifier>DOI: 10.1002/art.39515</identifier><identifier>PMID: 26841353</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Arthritis, Psoriatic - immunology ; Arthritis, Reactive - immunology ; Arthritis, Rheumatoid - immunology ; Blotting, Western ; Case-Control Studies ; CD4-Positive T-Lymphocytes - immunology ; Cell Differentiation - immunology ; Cytokines - immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Flow Cytometry ; HLA-B27 Antigen - immunology ; HLA-B27 Antigen - metabolism ; Humans ; Immunoglobulins ; Lymphocytes ; Male ; Middle Aged ; Polymerase chain reaction ; Receptors, Antigen, T-Cell - genetics ; Receptors, KIR3DL2 - immunology ; Receptors, KIR3DL2 - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Spondylarthropathies - immunology ; Spondylitis, Ankylosing - immunology ; Spondyloarthritis ; T cell receptors ; T-Lymphocytes - immunology ; Th17 Cells - immunology ; Transcriptome ; Young Adult</subject><ispartof>Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.901-914</ispartof><rights>2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology.</rights><rights>2016, American College of Rheumatology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93</citedby><cites>FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26841353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ridley, Anna</creatorcontrib><creatorcontrib>Hatano, Hiroko</creatorcontrib><creatorcontrib>Wong‐Baeza, Isabel</creatorcontrib><creatorcontrib>Shaw, Jacqueline</creatorcontrib><creatorcontrib>Matthews, Katherine K.</creatorcontrib><creatorcontrib>Al‐Mossawi, Hussein</creatorcontrib><creatorcontrib>Ladell, Kristin</creatorcontrib><creatorcontrib>Price, David A.</creatorcontrib><creatorcontrib>Bowness, Paul</creatorcontrib><creatorcontrib>Kollnberger, Simon</creatorcontrib><title>Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis</title><title>Arthritis & rheumatology (Hoboken, N.J.)</title><addtitle>Arthritis Rheumatol</addtitle><description>Objective
In the spondyloarthritides (SpA), increased numbers of CD4+ T cells express killer cell immunoglobulin‐like receptor 3DL2 (KIR‐3DL2). The aim of this study was to determine the factors that induce KIR‐3DL2 expression, and to characterize the relationship between HLA–B27 and the phenotype and function of KIR‐3DL2–expressing CD4+ T cells in SpA.
Methods
In total, 34 B27+ patients with SpA, 28 age‐ and sex‐matched healthy controls (20 B27− and 8 B27+), and 9 patients with rheumatoid arthritis were studied. KIR-3DL2 expression and other phenotypic characteristics of peripheral blood and synovial fluid CD4+ T cells were studied by flow cytometry, quantitative polymerase chain reaction, and Western blotting. T cell receptor clonality was determined by template‐switch anchored reverse transcription–polymerase chain reaction and sequencing analysis. Cytokines were measured by enzyme‐linked immunosorbent assay.
Results
Cellular activation induced KIR‐3DL2 expression on both naive and effector CD4+ T cells. KIR‐3DL2 binding to B27+ cells promoted expression of KIR‐3DL2, the Th17‐specific transcription factor retinoic acid receptor–related orphan nuclear receptor γt, and the antiapoptotic factor B cell lymphoma 2. KIR‐3DL2+CD4+ T cells in patients with ankylosing spondylitis were oligoclonal and enriched for markers of T cell activation and for the gut homing receptor CCR9. In the presence of B27+ antigen‐presenting cells, KIR‐3DL2+CD4+ T cells produced less interleukin‐2 (IL‐2) but more IL‐17. This effect was blocked by HC10, an antibody that inhibits the binding of KIR‐3DL2 to B27 heavy chains.
Conclusion
KIR‐3DL2 binding to HLA–B27 licenses Th17 cell differentiation in SpA. These findings raise the therapeutic potential of targeting HLA–B27–KIR‐3DL2 interactions for the treatment of B27+ patients with SpA.</description><subject>Adult</subject><subject>Aged</subject><subject>Arthritis, Psoriatic - immunology</subject><subject>Arthritis, Reactive - immunology</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Blotting, Western</subject><subject>Case-Control Studies</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Cell Differentiation - immunology</subject><subject>Cytokines - immunology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>HLA-B27 Antigen - immunology</subject><subject>HLA-B27 Antigen - metabolism</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Polymerase chain reaction</subject><subject>Receptors, Antigen, T-Cell - genetics</subject><subject>Receptors, KIR3DL2 - immunology</subject><subject>Receptors, KIR3DL2 - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Spondylarthropathies - immunology</subject><subject>Spondylitis, Ankylosing - immunology</subject><subject>Spondyloarthritis</subject><subject>T cell receptors</subject><subject>T-Lymphocytes - immunology</subject><subject>Th17 Cells - immunology</subject><subject>Transcriptome</subject><subject>Young Adult</subject><issn>2326-5191</issn><issn>2326-5205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqNktFqFDEYhQdRbFl74QtIwBu92HaSTJKZG2G7Vbu4oNT1OmQy_-ymZpJtMlPZuz5CoVe-Xp_EbLctKgjmJoH_4-Q_h5NlL3F-iPOcHKnQH9KKYfYk2yeU8DEjOXv68MYV3ssOYjzP06lEznP2PNsjvCwwZXQ_-znRvblUvfHu9up65ppBQ4M-GWshoClYi2ZdNzi_tL4erNlC1nwHdAYa1r0PiJ7MCTo2rjFuiXqPTueT26ubYyLQ3GhwESL6ovqVX4IzGi12miembSGA683dz8g49HXtXbOxPtlZBdOb-CJ71iob4eD-HmXfPrxfTE_H888fZ9PJfKwLwdm4ZboGwjgvAbiodCWKoimp4LimWFWV4lTjZFsVbZMDNIVmTZ0iAkp0yaGio-zdTnc91B00aec-KCvXwXQqbKRXRv45cWYll_5SFiVjPMU4yt7cCwR_MUDsZWeiTjaVAz9EiUXJCC0xzf8DFaIoBStIQl__hZ77IbiUxJbiVGDGtoJvd5QOPsYA7ePeOJfbesiUp7yrR2Jf_W70kXwoQwKOdsAPY2HzbyU5OVvsJH8BxV7IKQ</recordid><startdate>201604</startdate><enddate>201604</enddate><creator>Ridley, Anna</creator><creator>Hatano, Hiroko</creator><creator>Wong‐Baeza, Isabel</creator><creator>Shaw, Jacqueline</creator><creator>Matthews, Katherine K.</creator><creator>Al‐Mossawi, Hussein</creator><creator>Ladell, Kristin</creator><creator>Price, David A.</creator><creator>Bowness, Paul</creator><creator>Kollnberger, Simon</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201604</creationdate><title>Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis</title><author>Ridley, Anna ; Hatano, Hiroko ; Wong‐Baeza, Isabel ; Shaw, Jacqueline ; Matthews, Katherine K. ; Al‐Mossawi, Hussein ; Ladell, Kristin ; Price, David A. ; Bowness, Paul ; Kollnberger, Simon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Arthritis, Psoriatic - immunology</topic><topic>Arthritis, Reactive - immunology</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Blotting, Western</topic><topic>Case-Control Studies</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Cell Differentiation - immunology</topic><topic>Cytokines - immunology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>HLA-B27 Antigen - immunology</topic><topic>HLA-B27 Antigen - metabolism</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Polymerase chain reaction</topic><topic>Receptors, Antigen, T-Cell - genetics</topic><topic>Receptors, KIR3DL2 - immunology</topic><topic>Receptors, KIR3DL2 - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Spondylarthropathies - immunology</topic><topic>Spondylitis, Ankylosing - immunology</topic><topic>Spondyloarthritis</topic><topic>T cell receptors</topic><topic>T-Lymphocytes - immunology</topic><topic>Th17 Cells - immunology</topic><topic>Transcriptome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ridley, Anna</creatorcontrib><creatorcontrib>Hatano, Hiroko</creatorcontrib><creatorcontrib>Wong‐Baeza, Isabel</creatorcontrib><creatorcontrib>Shaw, Jacqueline</creatorcontrib><creatorcontrib>Matthews, Katherine K.</creatorcontrib><creatorcontrib>Al‐Mossawi, Hussein</creatorcontrib><creatorcontrib>Ladell, Kristin</creatorcontrib><creatorcontrib>Price, David A.</creatorcontrib><creatorcontrib>Bowness, Paul</creatorcontrib><creatorcontrib>Kollnberger, Simon</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arthritis & rheumatology (Hoboken, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ridley, Anna</au><au>Hatano, Hiroko</au><au>Wong‐Baeza, Isabel</au><au>Shaw, Jacqueline</au><au>Matthews, Katherine K.</au><au>Al‐Mossawi, Hussein</au><au>Ladell, Kristin</au><au>Price, David A.</au><au>Bowness, Paul</au><au>Kollnberger, Simon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis</atitle><jtitle>Arthritis & rheumatology (Hoboken, N.J.)</jtitle><addtitle>Arthritis Rheumatol</addtitle><date>2016-04</date><risdate>2016</risdate><volume>68</volume><issue>4</issue><spage>901</spage><epage>914</epage><pages>901-914</pages><issn>2326-5191</issn><eissn>2326-5205</eissn><abstract>Objective
In the spondyloarthritides (SpA), increased numbers of CD4+ T cells express killer cell immunoglobulin‐like receptor 3DL2 (KIR‐3DL2). The aim of this study was to determine the factors that induce KIR‐3DL2 expression, and to characterize the relationship between HLA–B27 and the phenotype and function of KIR‐3DL2–expressing CD4+ T cells in SpA.
Methods
In total, 34 B27+ patients with SpA, 28 age‐ and sex‐matched healthy controls (20 B27− and 8 B27+), and 9 patients with rheumatoid arthritis were studied. KIR-3DL2 expression and other phenotypic characteristics of peripheral blood and synovial fluid CD4+ T cells were studied by flow cytometry, quantitative polymerase chain reaction, and Western blotting. T cell receptor clonality was determined by template‐switch anchored reverse transcription–polymerase chain reaction and sequencing analysis. Cytokines were measured by enzyme‐linked immunosorbent assay.
Results
Cellular activation induced KIR‐3DL2 expression on both naive and effector CD4+ T cells. KIR‐3DL2 binding to B27+ cells promoted expression of KIR‐3DL2, the Th17‐specific transcription factor retinoic acid receptor–related orphan nuclear receptor γt, and the antiapoptotic factor B cell lymphoma 2. KIR‐3DL2+CD4+ T cells in patients with ankylosing spondylitis were oligoclonal and enriched for markers of T cell activation and for the gut homing receptor CCR9. In the presence of B27+ antigen‐presenting cells, KIR‐3DL2+CD4+ T cells produced less interleukin‐2 (IL‐2) but more IL‐17. This effect was blocked by HC10, an antibody that inhibits the binding of KIR‐3DL2 to B27 heavy chains.
Conclusion
KIR‐3DL2 binding to HLA–B27 licenses Th17 cell differentiation in SpA. These findings raise the therapeutic potential of targeting HLA–B27–KIR‐3DL2 interactions for the treatment of B27+ patients with SpA.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>26841353</pmid><doi>10.1002/art.39515</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2326-5191 |
ispartof | Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.901-914 |
issn | 2326-5191 2326-5205 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4855641 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Adult Aged Arthritis, Psoriatic - immunology Arthritis, Reactive - immunology Arthritis, Rheumatoid - immunology Blotting, Western Case-Control Studies CD4-Positive T-Lymphocytes - immunology Cell Differentiation - immunology Cytokines - immunology Enzyme-Linked Immunosorbent Assay Female Flow Cytometry HLA-B27 Antigen - immunology HLA-B27 Antigen - metabolism Humans Immunoglobulins Lymphocytes Male Middle Aged Polymerase chain reaction Receptors, Antigen, T-Cell - genetics Receptors, KIR3DL2 - immunology Receptors, KIR3DL2 - metabolism Reverse Transcriptase Polymerase Chain Reaction Spondylarthropathies - immunology Spondylitis, Ankylosing - immunology Spondyloarthritis T cell receptors T-Lymphocytes - immunology Th17 Cells - immunology Transcriptome Young Adult |
title | Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A26%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%E2%80%90Induced%20Killer%20Cell%20Immunoglobulin%E2%80%90like%20Receptor%203DL2%20Binding%20to%20HLA%E2%80%93B27%20Licenses%20Pathogenic%20T%20Cell%20Differentiation%20in%20Spondyloarthritis&rft.jtitle=Arthritis%20&%20rheumatology%20(Hoboken,%20N.J.)&rft.au=Ridley,%20Anna&rft.date=2016-04&rft.volume=68&rft.issue=4&rft.spage=901&rft.epage=914&rft.pages=901-914&rft.issn=2326-5191&rft.eissn=2326-5205&rft_id=info:doi/10.1002/art.39515&rft_dat=%3Cproquest_pubme%3E1777487542%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4765-f5cbe25668ee679c9744d83761b31a99a63c1060a4fd0eed4c5db520e32c86e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1776371550&rft_id=info:pmid/26841353&rfr_iscdi=true |